Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clozapine for Cannabis Use Disorder in Schizophrenia

NCT01639872 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.

NCT NCT01639872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01639872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clozapine for Cannabis Use Disorder in Schizophrenia
Lead sponsor
Dartmouth-Hitchcock Medical Center
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2013
Completion date
March 29, 2017
Enrollment
49 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis abuse, cannabis dependence, dual diagnosis, schizophrenia